Therefore, TSPO may represent an attractive target for the study of skeletal muscle involvement in ALS pathophysiology at two levels: (a) as a marker of muscle inflammation and (b) as an indicator of mitochondrial alterations. This evidence concerns the gene TSPO and amyotrophic lateral sclerosis.